NCT07213791 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07213791
Title	A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)
Acronym	FiREBOLT
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Eli Lilly and Company
Indications	colorectal cancer esophagus adenocarcinoma cholangiocarcinoma esophagus squamous cell carcinoma gastric adenocarcinoma Her2-receptor positive breast cancer triple-receptor negative breast cancer Her2-receptor negative breast cancer ovarian cancer pancreatic adenocarcinoma Advanced Solid Tumor
Therapies	LY4337713
Age Groups:	adult \| senior
Covered Countries	USA \| NLD

NCT07213791
Clinical Trial Detail